One of the treatments for ASD we at Cell El Ltd look forward to observing and researching is Autologous Mesenchymal Stem Cell (MSC) therapy. MSC treatment involves injection of stem cells taken from the patient’s own bone marrow and injected back into the patient’s central nervous system (via cerebro-spinal fluid). Previously (Part 2 above) we reviewed promising research relating to addressing the underlying immune dysfunction afflicting many children with ASD. Autologous Mesenchymal Stem Cell (MSC) therapy utilizes the child’s own immune modulating stem cells to strengthen the immune system. This experimental treatment is associated with enhanced development in children with ASD. (More details about this can be found on our website Therapy page/ as well as in our article: Therapeutic properties of mesenchymal stem cells for autism spectrum disorders ).
At Cell-El Ltd we are exploring the positive effect of a protocol for MSC therapy which utilizes cells harvested from the child’s own body that are most likely to be successful, i.e. not rejected by the body. The MSC clinical study protocol focuses on fresh cells (implanted immediately after harvesting) to enhance viability and efficacy. In our study, we are looking both at how Stem Cell therapy may enhance behavioral, social behavior in children with ASD, as well as possible alteration to their immune system, and synergy between the two. Please join us in making a difference in the lives of children with ASD and their families! We are recruiting both participants who are typically developing as well as those diagnosed with ASD. We are also looking for parents to help spread the word to others and thus enable this important tool to be integrated into Autism treatment as quickly as possible. And we want to hear from you about your concerns and challenges relating to ASD testing and related therapies. To contact us and learn more please click here.